4//SEC Filing
DESOUZA ERROL B 4
Accession 0000950103-21-009693
CIK 0001802768other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 8:34 PM ET
Size
11.3 KB
Accession
0000950103-21-009693
Insider Transaction Report
Form 4
DESOUZA ERROL B
Director
Transactions
- Award
Class A Ordinary Shares
2021-06-25+5,726→ 50,370 total
Footnotes (1)
- [F1]Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.
Issuer
Royalty Pharma plc
CIK 0001802768
Entity typeother
Related Parties
1- filerCIK 0001213895
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 8:34 PM ET
- Size
- 11.3 KB